New nonlinear control method stabilizes resonant power delivery during rapid plasma load changes, advancing a key building block of nT-Tao's...
AUSTIN, Texas, Dec. 15, 2025 /PRNewswire/ -- OsteoCentric Technologies announced today the appointment of RJ Brideau to its Board of...
Investment to Accelerate Product Innovation and Customer Experience to Better Serve Aesthetics & Wellness PracticesAUSTIN, Texas, Dec. 15, 2025 /PRNewswire/...
Funnel Boost Media reports that targeted SEO improvements for a multi-location vein clinic and an urban dental practice produced triple-digit...
BOSTON, Dec. 15, 2025 /PRNewswire/ -- Basys.ai, an agentic AI-powered prior authorization and utilization management platform, has been selected by...
Company to Launch AI Food & Recipe App to Access Trillion-Dollar Global Food Market While Advancing Medical AI Pipeline MESA,...
London, United Kingdom--(Newsfile Corp. - December 15, 2025) - Edison issues report on VinFast Auto (NASDAQ: VFS).VinFast Auto (VFS) is...
London, United Kingdom--(Newsfile Corp. - December 15, 2025) - Edison issues report on VinFast Auto (NASDAQ: VFS).VinFast Auto (VFS) is...
Winter Park, Florida--(Newsfile Corp. - December 15, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), a leader in regenerative medicine through...
Winter Park, Florida--(Newsfile Corp. - December 15, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), a leader in regenerative medicine through...
VALENCIA, Calif.--(BUSINESS WIRE)--SetPoint Medical, a commercial-stage medical technology company dedicated to improving care for people living with chronic autoimmune diseases,...
NEW YORK--(BUSINESS WIRE)--SK Capital Partners, LP (“SK Capital”), a New York-based private investment firm focused on the life sciences, specialty...
Atlanta, Georgia--(Newsfile Corp. - December 15, 2025) - Apyron, Inc. is a medical technology company with a product portfolio designed...
EXXUA is now available through Aytu RxConnect® pharmacies to ensure optimal access and availabilityEXXUA has demonstrated significant improvement in depression...
SBS-IF is the second orphan disease target indication for Jaguar's intestinal failure program, which includes microvillus inclusion disease (MVID) -...
mNEXSPIKE is Moderna's third product to receive a positive CHMP opinion alongside Spikevax (COVID-19 Vaccine, mRNA) and mRESVIA (Respiratory Syncytial...
Promising data show a median overall survival of 18.6 months, with 40% of patients alive at 2 years. Results suggest...
New program pairs microdoses of GLP-1 medication with Noom’s powerful behavior-change program and at-home biomarker testing to track the health...
37.8% of voting rights present or representedAll resolutions were approved MADRID and CAMBRIDGE, Mass., Dec. 15, 2025 (GLOBE NEWSWIRE) --...
Southlake, TX, Dec. 15, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), a healthcare information...